泰和新材(002254.SZ):公司新業務都要求必須進行項目跟投
格隆匯6月7日丨有投資者向泰和新材(002254.SZ)提問:公司新業務設置子公司的考慮?
泰和新材回覆:公司新業務都要求必須進行項目跟投,想法是讓骨幹員工一起參與企業經營,調動積極性,自發去幹,這是設置跟投的初衷。以前我們做員工持股是因為當時的業務相對比較簡單,風險相對可控,而現在新項目芳綸隔膜、綠色印染在全球都是前沿的,市場、技術都不是可控的,這種業務是創新業務,集團有個辦法是類似這種業務都是強制跟投,對我們來説首先是風險測試,看看經營團隊和決策層對項目有沒有信心,敢不敢往裏投錢;第二個是讓團隊把公司的事當成自己的事,把創新業務儘快做起來,隔膜的項目進度一直超預期,就是達到了這種效果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.